Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 4Completed 2Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Gynecologic 1

Conditions

Uterine Cervical Neoplasms 132Ovarian Neoplasms 109Endometrial Neoplasms 81Uterine Cervical Dysplasia 19Papillomavirus Infections 17Breast Neoplasms 17Fallopian Tube Neoplasms 15Carcinoma, Ovarian Epithelial 15Colorectal Neoplasms 13Carcinoma, Non-Small-Cell Lung 12Neoplasms 11Vulvar Neoplasms 10Neoplasm Metastasis 10Recurrence 9Prostatic Neoplasms 9Endometrial Hyperplasia 9Cervical Cancer Screening 9Acquired Immunodeficiency Syndrome 8Uterine Neoplasms 7Stomach Neoplasms 7Squamous Intraepithelial Lesions 6Locally Advanced Cervical Cancer 6Anus Neoplasms 6Vaginal Neoplasms 5Triple Negative Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Pelvic Neoplasms 5Pancreatic Neoplasms 5Melanoma 5

Interventions

inavolisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Hereditary Sensory and Autonomic Neuropathies × Gynecologic × Clear all
NCT07522697 2026-04-13

MITO END-4

National Cancer Institute, Naples

Phase 2 Not yet recruiting
48 enrolled
Gynecologic

Hereditary Sensory and Autonomic Neuropathies, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡